Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on rare disease therapeutics, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference.

Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on rare disease therapeutics, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management will engage in a fireside chat on Thursday, December 5, 2024, at 9:00 AM Eastern Time. Interested parties can access both the live audio webcast and replay through the Investors section of Soleno's website at www.soleno.life.

Argus Session date unavailable

-4.29% session move Open Argus

Details

News Market Reaction – SLNO

The recorded move for SLNO in the trading session of this news was -4.29%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36^th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time.

A live audio webcast and replay of the fireside chat will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. An NDA for its lead candidate, DCCR (diazoxide choline) extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS) is currently under review by the FDA and was granted Priority Review. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Soleno Therapeutics (SLNO) presenting at the Piper Sandler Healthcare Conference 2024?

Soleno Therapeutics (SLNO) will present at the Piper Sandler Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time.

How can I watch Soleno Therapeutics' (SLNO) presentation at the Piper Sandler Conference?

You can watch the live audio webcast and replay of Soleno Therapeutics' fireside chat through the Investors section on the company's website at www.soleno.life.

What type of event will Soleno Therapeutics (SLNO) participate in at the Piper Sandler Conference?

Soleno Therapeutics will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference.